Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,068 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methotrimeprazine is a neuroprotective antiviral in JEV infection via adaptive ER stress and autophagy.
Prajapat SK, Mishra L, Khera S, Owusu SD, Ahuja K, Sharma P, Choudhary E, Chhabra S, Kumar N, Singh R, Kaushal PS, Mahajan D, Banerjee A, Motiani RK, Vrati S, Kalia M. Prajapat SK, et al. Among authors: chhabra s. EMBO Mol Med. 2024 Jan;16(1):185-217. doi: 10.1038/s44321-023-00014-w. Epub 2024 Jan 2. EMBO Mol Med. 2024. PMID: 38177535 Free PMC article.
Guanylate-binding proteins in virus infection.
Chhabra S, Kalia M. Chhabra S, et al. Biochem Soc Trans. 2023 Aug 31;51(4):1621-1633. doi: 10.1042/BST20221500. Biochem Soc Trans. 2023. PMID: 37534998
Japanese Encephalitis Virus-Infected Cells.
Sharma KB, Chhabra S, Kalia M. Sharma KB, et al. Among authors: chhabra s. Subcell Biochem. 2023;106:251-281. doi: 10.1007/978-3-031-40086-5_10. Subcell Biochem. 2023. PMID: 38159231
Is it time to erase the blue (pipe)line?
Bhatia P, Chhabra S. Bhatia P, et al. Among authors: chhabra s. J Anaesthesiol Clin Pharmacol. 2024 Oct-Dec;40(4):555-556. doi: 10.4103/joacp.joacp_558_24. Epub 2024 Dec 3. J Anaesthesiol Clin Pharmacol. 2024. PMID: 39759032 Free PMC article. No abstract available.
Donor Type Does Not Impact Late Graft Failure Following Reduced Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Based Graft-Versus-Host Disease Prophylaxis.
Hickey CL, Zhang MJ, Allbee-Johnson M, Romee R, Majhail NS, Malki MMA, Antin JH, Benjamin CL, Bredeson C, Chhabra S, Grunwald MR, Inamoto Y, Kanakry CG, Milano F, Soiffer RJ, Solomon SR, Spellman SR, Brunstein CG, Cutler C. Hickey CL, et al. Among authors: chhabra s. Transplant Cell Ther. 2025 Jan 2:S2666-6367(24)00840-6. doi: 10.1016/j.jtct.2024.12.021. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39755256
1,068 results